Slc26a9-KO Mouse
Common Name
Slc26a9-KO
제품 ID
S-KO-18553
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-320718-Slc26a9-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Slc26a9-KO Mouse (카탈로그 번호 S-KO-18553)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Slc26a9-KO
품종 계통계통 ID
KOCMP-320718-Slc26a9-B6J-VB
유전자명
제품 ID
S-KO-18553
유전자 별칭
E030002L01Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 1
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000049027
NCBI 전사체 ID
NM_177243
타겟 영역
Exon 3~5
유효 영역 크기
~2.3 kb
유전자 연구 개요
Slc26a9 is a member of the SLC26A family of anion transporters, functioning as a Cl-transporter across various epithelia [1,2,3,4,5,6,7,8,9,10]. It is involved in ion transport mechanisms and plays a role in maintaining acid-base homeostasis, especially in epithelia where it mediates Cl-absorption and HCO3-secretion [8]. It has been associated with pathways like Wnt/β-catenin signaling, and is of biological importance in multiple organs including the respiratory system, gastrointestinal tract, male tissues, and skin [1,3,6]. Genetic models such as gene-knockout (KO) mouse models have been crucial in studying its functions [1,6].
In Slc26a9-knockout animals, neonatal distress and early death occur, likely due to its role in fluid reabsorption in the alveolar space [1]. In the gastrointestinal tract, Slc26a9-deficient mice show spontaneous development of gastric premalignant and malignant lesions, with dysregulated differentiation of gastric stem cells, activated Wnt signaling, hyperproliferation, apoptosis inhibition, and metaplasia [6]. In colorectal cancer cell lines and mouse models, down-regulation of Slc26a9 induced cell cycle arrest and apoptosis, while inhibiting cell proliferation and xenograft tumor growth, indicating its role in promoting colorectal tumorigenesis through modulating Wnt/β-catenin signaling [3].
In conclusion, Slc26a9 is essential for maintaining proper ion and fluid balance in multiple organs. The study of Slc26a9 KO mouse models has revealed its role in various disease conditions, such as neonatal distress, gastric intraepithelial neoplasia, and colorectal cancer. Understanding its functions provides new possibilities for disease therapy, especially in diseases related to abnormal ion transport and epithelial cell homeostasis [1,3,6,8].
References:
1. Kunzelmann, Karl, Centeio, Raquel, Ousingsawat, Jiraporn, Seidler, Ursula, Schreiber, Rainer. . SLC26A9 in airways and intestine: secretion or absorption? In Channels (Austin, Tex.), 17, 2186434. doi:10.1080/19336950.2023.2186434. https://pubmed.ncbi.nlm.nih.gov/36866602/
2. Gorrieri, Giulia, Zara, Federico, Scudieri, Paolo. 2022. SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease. In Biomolecules, 12, . doi:10.3390/biom12020202. https://pubmed.ncbi.nlm.nih.gov/35204703/
3. Zhang, Minglin, Ma, Zhiyuan, Yi, Zhiqiang, Li, Taolang, Liu, Xuemei. 2024. SLC26A9 promotes colorectal tumorigenesis by modulating Wnt/β-catenin signaling. In Cell death discovery, 10, 123. doi:10.1038/s41420-024-01888-6. https://pubmed.ncbi.nlm.nih.gov/38461207/
4. Kunzelmann, Karl, Ousingsawat, Jiraporn, Kraus, Andre, Schreiber, Rainer, Buchholz, Björn. 2023. Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins. In International journal of molecular sciences, 24, . doi:10.3390/ijms241713278. https://pubmed.ncbi.nlm.nih.gov/37686084/
5. Ousingsawat, Jiraporn, Centeio, Raquel, Schreiber, Rainer, Kunzelmann, Karl. 2022. Expression of SLC26A9 in Airways and Its Potential Role in Asthma. In International journal of molecular sciences, 23, . doi:10.3390/ijms23062998. https://pubmed.ncbi.nlm.nih.gov/35328418/
6. Liu, Xuemei, Li, Taolang, Ma, Zhiyuan, Seidler, Ursula, Tuo, Biguang. 2022. SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans. In Cellular oncology (Dordrecht, Netherlands), 45, 381-398. doi:10.1007/s13402-022-00672-x. https://pubmed.ncbi.nlm.nih.gov/35426084/
7. Balázs, Anita, Mall, Marcus A. 2018. Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis. In Frontiers in pharmacology, 9, 1112. doi:10.3389/fphar.2018.01112. https://pubmed.ncbi.nlm.nih.gov/30327603/
8. Liu, Xuemei, Li, Taolang, Tuo, Biguang. 2018. Physiological and Pathophysiological Relevance of the Anion Transporter Slc26a9 in Multiple Organs. In Frontiers in physiology, 9, 1197. doi:10.3389/fphys.2018.01197. https://pubmed.ncbi.nlm.nih.gov/30233393/
9. Pinto, Madalena C, Quaresma, Margarida C, Silva, Iris A L, Ramalho, Sofia S, Amaral, Margarida D. 2021. Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9. In International journal of molecular sciences, 22, . doi:10.3390/ijms222313064. https://pubmed.ncbi.nlm.nih.gov/34884866/
10. Needham, Patrick G, Goeckeler-Fried, Jennifer L, Zhang, Casey, Bertrand, Carol A, Brodsky, Jeffrey L. . SLC26A9 is selected for endoplasmic reticulum associated degradation (ERAD) via Hsp70-dependent targeting of the soluble STAS domain. In The Biochemical journal, 478, 4203-4220. doi:10.1042/BCJ20210644. https://pubmed.ncbi.nlm.nih.gov/34821356/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
